Followers | 353 |
Posts | 13825 |
Boards Moderated | 5 |
Alias Born | 09/27/2010 |
Tuesday, March 22, 2016 3:09:57 PM
Some data coming out should be followed by more good data, successful completion of human trials, the CE mark, and a product launch across Europe. I presume they likely already have everything in place such as distribution partner(s), etc.
Successful human trials = all data needed to clear a medical device through the FDA as quickly as possible.
Would like to see a continued move back into the 30s off of this and what's likely to come near term.
Everyone should own a lot of $ARTH
All my opinion.
Stay very disciplined and consistent.
Find what works for you and stick with it.
Identify support/resistance ranges to buy and sell.
Invest in the fundamentals, trade the technicals.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM